相关实验视频
Updated: May 28, 2025

08:41
Mouse Round Spermatid Injection
Published on: January 26, 2024
649
在用对抗剂协议进行体外受精期间影响多精子症的因素
Hongzhi Shi1, Qi Song2, Jiajia Liu3
1Hongzhi Shi Department of Reproductive Medicine, Maternity & Child Care Center of Qinhuangdao, Qinhuangdao 066000, Hebei, China.
Pakistan journal of medical sciences
|February 10, 2025
概括
人体胆性腺激素 (hCG) 注射当天的高性激素 (LH) 与体外受精 (IVF) 反对者协议中的多精子有关. 优化LH水平可能会改善胚胎的结果.
科学领域:
- 生殖医学 生殖医学
- 在体外受精 (IVF)
- 内分泌学 在内分泌学.
背景情况:
- 多精子症,即多个精子对卵子的受精,可能会对试管婴儿成功率产生负面影响.
- 反对者协议通常用于IVF中的受控卵巢刺激.
- 了解导致多精子症的因素对于优化试管婴儿结果至关重要.
研究的目的:
- 用对抗者协议在IVF中长期受精期间识别影响多精子症的因素.
- 为了研究激素水平和多精子发生率之间的关系.
主要方法:
- 一个回顾性病例控制研究,涉及536个试管婴儿周期,使用对抗剂协议.
- 患者被分为对照组 (0%多精子症) 和多精子症组 (≥20%多个前核).
- 对一般数据和胚胎发育进行了统计分析,包括后勤二进制回归.
主要成果:
- 两组之间在各种患者人口统计学,卵巢刺激参数或精子参数方面没有发现显著差异.
- 值得注意的是,在注射人类胆性淋巴激素 (hCG) 的当天,黄素化激素 (LH) 的水平被确定为多精子症的独立风险因素.
- 在女性年龄,雌激素,孕激素,卵泡数量,取出的卵子或受精度方面没有发现显著差异.
结论:
- 在hCG注射日的LH水平是IVF对抗剂协议中与多精子症相关的关键因素.
- 在排卵诱导期间适当调整LH水平,可能会在试管婴儿治疗中改善胚胎结果.
相关概念视频
Spermatogenesis
102.0K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.0K
Infertility in Males
235
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
235
In Vitro Fertilization
203
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
203
Meiosis II
182.6K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
182.6K
Fertilization
70.7K
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
70.7K

